61.
Cardiovascular disease in Noonan syndrome
by Prendiville, Terence W
Archives of disease in childhood, 2014-07, Vol.99 (7), p.629-634
62.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176
63.
Inactive Matrix Gla Protein Is Causally Related to Adverse Health Outcomes A Mendelian Randomization Study in a Flemish Population
by Liu, Yan-Ping
Hypertension (Dallas, Tex. 1979), 2015-02, Vol.65 (2), p.463-U497
64.
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine
by Green, Robert C
American journal of human genetics, 2016-06-02, Vol.98 (6), p.1051-1066
65.
Marginal role for 53 common genetic variants in cardiovascular disease prediction
by Morris, Richard W
Heart (British Cardiac Society), 2016-10, Vol.102 (20), p.1640-1647
66.
Unified Sequence-Based Association Tests Allowing for Multiple Functional Annotations and Meta-analysis of Noncoding Variation in Metabochip Data
by He, Zihuai
American journal of human genetics, 2017-09-07, Vol.101 (3), p.340-352
67.
Genetic association studies in cardiovascular diseases: Do we have enough power?
by Auer, Paul L
Trends in cardiovascular medicine, 2017, Vol.27 (6), p.397-404
68.
Chemerin, a Novel Adipokine in the Regulation of Angiogenesis
by Bozaoglu, Kiymet
The journal of clinical endocrinology and metabolism, 2010-05, Vol.95 (5), p.2476-2485
69.
Telomere biology in healthy aging and disease
by Oeseburg, Hisko
Pflügers Archiv, 2010-01, Vol.459 (2), p.259-268
70.
A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals
by Havulinna, Aki S
Hypertension (Dallas, Tex. 1979), 2013-05, Vol.61 (5), p.987-994
71.
Advances and Challenges in Cardiovascular Gene Therapy
by Lähteenvuo, Johanna
Human gene therapy, 2017-11-01, Vol.28 (11), p.124-1032
72.
Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits
by Yao, Chen
American journal of human genetics, 2017-04-06, Vol.100 (4), p.571-580
73.
A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity
by Marshall, Nichola J
Hypertension (Dallas, Tex. 1979), 2013-01, Vol.61 (1), p.246-252
74.
Arterial stiffness: a brief review
by Shirwany, Najeeb A
Acta pharmacologica Sinica, 2010-10, Vol.31 (10), p.1267-1276
75.
Differential Gene Expression in Granulosa Cells from Polycystic Ovary Syndrome Patients with and without Insulin Resistance: Identification of Susceptibility Gene Sets through Netw...
by Kaur, Surleen
The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.E2016-E2021
76.
Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin
by Cui, Mingli
Hypertension (Dallas, Tex. 1979), 2016-01, Vol.67 (1), p.153-162
77.
Thymidine phosphorylase: A potential new target for treating cardiovascular disease
by Li, Wei
Trends in cardiovascular medicine, 2018-04, Vol.28 (3), p.157-171
78.
Mendelian randomisation applied to drug development in cardiovascular disease: a review
by Mokry, Lauren E
Journal of Medical Genetics, 2015-02, Vol.52 (2), p.71-79
79.
Genome-Wide Identification of Long Noncoding RNAs in Rat Models of Cardiovascular and Renal Disease
by Gopalakrishnan, Kathirvel
Hypertension (Dallas, Tex. 1979), 2015-01, Vol.65 (1), p.200-210
80.
Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12, A1BG, and the Selectin Region and Cardiovascular Outcomes
by McDonough, Caitrin W
Hypertension (Dallas, Tex. 1979), 2013-07, Vol.62 (1), p.48-54
